You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 4.7% | 3.9% |
Div Cover | 2.4 | 3.0 |
Op Mrgn | 6.3% | 23.1% |
ROCE | 16.2% |
Latest | Forecast | |
---|---|---|
P/E | 8.9 | 0.0 |
PEG | -0.3 | 1.6 |
Price / Revenue | 1.2 | 1.1 |
Price / Book value | 0.7 |
Latest | Forecast | |
---|---|---|
Revenue | 2.6% | -6.7% |
PBT | -71.3% | n/a |
EPS | -33.0% | -27.1% |
DPS | 5.0% | -18.4% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 118.21 | 22.80 | 4.54p | 14.8 | -1.0 | -15% | 1.46p | 2.2% |
2019-12-31 | 135.64 | 31.08 | 5.09p | 16.5 | 1.4 | 12% | 0.54p | 0.6% |
2020-12-31 | 129.80 | 13.02 | 5.11p | 17.1 | 43.6 | 0% | 1.61p | 1.8% |
2021-12-31 | 163.21 | 18.16 | 6.39p | 17.0 | 0.7 | 25% | 1.69p | 1.6% |
2022-12-31 | 167.42 | 5.21 | 4.28p | 12.4 | -0.4 | -33% | 1.78p | 3.4% |
Alliance Pharma confident after some first-half setbacks Sharecast News | 26 Sep |
---|---|
Alliance Pharma reports resilient first-half trading Sharecast News | 18 Jul |
Currency headwinds to impact Alliance Pharma profits Sharecast News | 25 May |
Notification of Major Holdings | 09-Nov-23 11:19 |
---|---|
Appointment of Non-Executive Directors | 07-Nov-23 07:00 |
Total Voting Rights | 01-Nov-23 12:50 |
Director Dealings | 17-Oct-23 00:00 |
Notification of Major Interest in Shares | 13-Oct-23 00:00 |